Drug General Information (ID: DDIOHEXPRY)
  Drug Name Clofazimine Drug Info Polyethylene glycol (3350 with electrolytes) Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiinflammatory Agents Laxatives
  Structure

 Mechanism of Clofazimine-Polyethylene glycol (3350 with electrolytes) Interaction (Severity Level: Moderate)
     Increased risk of lowers seizure threshold Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Clofazimine Polyethylene glycol (3350 with electrolytes)
      Mechanism 1 Lower seizure threshold Lower seizure threshold
      Key Mechanism Factor 1
Factor Name Lowers seizure threshold
Factor Description The combination of medications that lower the seizure threshold is a factor that makes people with epilepsy more likely to have seizures. A seizure is a sudden, uncontrolled electrical disturbance in the brain that can cause changes in your behavior, movements or sensations, and level of consciousness.
      Mechanism Description
  • Increased risk of lowers seizure threshold by the combination of Clofazimine and Polyethylene glycol (3350 with electrolytes) 
     Increased risk of ventricular arrhythmias Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Clofazimine Polyethylene glycol (3350 with electrolytes)
      Mechanism 2 Prolong QT interval Electrolyte disturbances
      Key Mechanism Factor 2
Factor Name Ventricular arrhythmias
Factor Description Ventricular arrhythmias are abnormal heart rhythms that cause your heart's lower chambers to pump blood instead of pumping it. This can limit or stop your heart from supplying blood to your body. While some of these arrhythmias are harmless and do not cause symptoms, others can have serious, even fatal, effects on your body.
      Mechanism Description
  • Increased risk of ventricular arrhythmias by the combination of Clofazimine and Polyethylene glycol (3350 with electrolytes) 

Recommended Action
      Management Caution is advised when bowel cleansing preparations are prescribed in patients treated with drugs that prolong the QT interval. Patients should be advised to seek prompt medical attention if they experience symptoms that could indicate the occurrence of torsade de pointes such as dizziness, lightheadedness, fainting, palpitation, irregular heart rhythm, shortness of breath, or syncope.

References
1 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2 Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
3 Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.